Chronological analysis of B4002⁻granulocytes. The percentages of B4002⁻ granulocytes in case 16 (A) and case 20 (B) were determined several times after ATG/CsA therapy. Both patients responded to the therapy, and their hematological recovery was associated with a decrease in the B4002⁻ granulocyte percentage.